ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2019

Butyrolactone-I, an efficient α-glucosidase inhibitor, improves type 2 diabetes with potent TNF-α-lowering properties through modulating gut microbiota in db/db mice.

Wei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.